143 related articles for article (PubMed ID: 8730554)
21. Adoptive immunotherapy after bone marrow transplantation in a patient with relapsed acute myeloid leukaemia and severe psoriasis.
Windrum P; Jones FG; McMullin MF
Bone Marrow Transplant; 2004 Aug; 34(3):281-2. PubMed ID: 15156169
[No Abstract] [Full Text] [Related]
22. [Diagnostics and therapy of acute myeloid leukemia].
Fritsch S; Metzeler K; Hiddemann W; Buske C
Dtsch Med Wochenschr; 2006 Oct; 131(43):2401-6. PubMed ID: 17054056
[No Abstract] [Full Text] [Related]
23. Outcome of a multicenter treatment program including autologous or allogeneic bone marrow transplantation for de novo acute myeloid leukemia.
Wahlin A; Brinch L; Hörnsten P; Evensen SA; Oberg G; Simonsson B; Hedenus M
Eur J Haematol; 1997 Apr; 58(4):233-40. PubMed ID: 9186533
[TBL] [Abstract][Full Text] [Related]
24. Meta-analysis of autologous bone marrow transplantation versus chemotherapy in adult patients with acute myeloid leukemia in first remission.
Levi I; Grotto I; Yerushalmi R; Ben-Bassat I; Shpilberg O
Leuk Res; 2004 Jun; 28(6):605-12. PubMed ID: 15120937
[TBL] [Abstract][Full Text] [Related]
25. A systematic overview of chemotherapy effects in acute myeloid leukaemia.
Kimby E; Nygren P; Glimelius B;
Acta Oncol; 2001; 40(2-3):231-52. PubMed ID: 11441935
[TBL] [Abstract][Full Text] [Related]
26. Use of peripheral blood stem cells for autologous transplantation in acute myeloid leukemia patients allows faster engraftment and equivalent disease-free survival compared with bone marrow cells.
Visani G; Lemoli R; Tosi P; Martinelli G; Testoni N; Ricci P; Motta M; Gherlinzoni F; Leopardi G; Pastano R; Rizzi S; Piccaluga P; Isidori A; Tura S
Bone Marrow Transplant; 1999 Sep; 24(5):467-72. PubMed ID: 10482929
[TBL] [Abstract][Full Text] [Related]
27. Outcome in children with relapsed acute myeloid leukemia after initial treatment with the French Leucemie Aique Myeloide Enfant (LAME) 89/91 protocol of the French Society of Pediatric Hematology and Immunology.
Aladjidi N; Auvrignon A; Leblanc T; Perel Y; Bénard A; Bordigoni P; Gandemer V; Thuret I; Dalle JH; Piguet C; Pautard B; Baruchel A; Leverger G;
J Clin Oncol; 2003 Dec; 21(23):4377-85. PubMed ID: 14645428
[TBL] [Abstract][Full Text] [Related]
28. Treatment of the newly diagnosed adult with de novo acute myeloid leukemia.
Stone RM; Mayer RJ
Hematol Oncol Clin North Am; 1993 Feb; 7(1):47-64. PubMed ID: 8449864
[TBL] [Abstract][Full Text] [Related]
29. Postremission therapy in older adults with acute myeloid leukemia: an opportunity for new drug development.
Schiffer CA
Leukemia; 2002 Apr; 16(4):745-7. PubMed ID: 11960360
[No Abstract] [Full Text] [Related]
30. Bone marrow transplantation: its biology and role as treatment for acute and chronic leukemias.
Champlin R; Gale RP
Ann N Y Acad Sci; 1987; 511():447-58. PubMed ID: 2830829
[No Abstract] [Full Text] [Related]
31. Wider benefits of leukodepletion of blood products.
Copplestone JA; Williamson P; Norfolk DR; Morgenstern GR; Wimperis JZ; Williamson LM
Blood; 1995 Jul; 86(1):409-10. PubMed ID: 7795251
[No Abstract] [Full Text] [Related]
32. Understanding the mechanism of cure of acute myeloid leukemia by allogeneic bone marrow transplantation: toward the application of interleukin-2 in autologous bone marrow transplantation.
Prentice HG; MacDonald ID; Hamon MD
J Hematother; 1994; 3(1):47-50. PubMed ID: 7922008
[TBL] [Abstract][Full Text] [Related]
33. Is allogeneic bone marrow transplantation the best treatment for young adult patients with acute myeloid leukemia in first complete remission. The BGMT Group.
Reiffers J; Stoppa AM; Rigal-Huguet F; Michallet M; Marit G; Blaise D; Attal M; Corront B; Cony-Makhoul P; Gastaut JA
Leukemia; 1992; 6 Suppl 2():124-6. PubMed ID: 1578913
[No Abstract] [Full Text] [Related]
34. Does more intensive treatment cure more patients with acute myeloid leukemia? The BGMT Group.
Reiffers J; Maraninchi D; Rigal-Huguet F; Michallet M; Marit G; Stoppa AM; Attal M; Hollard D
Semin Hematol; 1991 Jul; 28(3 Suppl 4):90-2. PubMed ID: 1780761
[No Abstract] [Full Text] [Related]
35. Bone marrow transplantation in leukemia: experience of Pesaro.
Galimberti M; Polchi P; Delfini C; Angelucci E; Baronciani D; Giardini C; Manenti F; Politi P; Lucarelli G
Acta Haematol; 1987; 78 Suppl 1():187-9. PubMed ID: 3124445
[TBL] [Abstract][Full Text] [Related]
36. Intensive chemotherapy with or without additional bone marrow transplantation in paediatric AML: progress report on the MRC AML 10 trial. Medical Research Council Working Party on Childhood Leukaemia.
Stevens RF; Hann IM; Wheatley K; Gray R
Leukemia; 1992; 6 Suppl 2():55-8. PubMed ID: 1578942
[TBL] [Abstract][Full Text] [Related]
37. Emerging treatments in acute myeloid leukaemia.
Kell J
Expert Opin Emerg Drugs; 2004 May; 9(1):55-71. PubMed ID: 15155136
[TBL] [Abstract][Full Text] [Related]
38. Transplantation of patients with high risk acute myeloid leukemia in first remission with autologous marrow cultured in interleukin-2 followed by interleukin-2 administration.
Klingemann HG; Eaves CJ; Barnett MJ; Eaves AC; Hogge DE; Nantel SH; Reece E; Shepherd JD; Sutherland HJ; Phillips GL
Bone Marrow Transplant; 1994 Sep; 14(3):389-96. PubMed ID: 7994260
[TBL] [Abstract][Full Text] [Related]
39. Autologous bone marrow transplantation versus intensive consolidation chemotherapy for acute myeloid leukemia in childhood. Pediatric Oncology Group.
Ravindranath Y; Yeager AM; Chang MN; Steuber CP; Krischer J; Graham-Pole J; Carroll A; Inoue S; Camitta B; Weinstein HJ
N Engl J Med; 1996 May; 334(22):1428-34. PubMed ID: 8618581
[TBL] [Abstract][Full Text] [Related]
40. The current status of therapy for and prevention of blast crisis of chronic myelocytic leukemia.
Wiernik PH
J Clin Oncol; 1984 Apr; 2(4):329-35. PubMed ID: 6368762
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
